711 related articles for article (PubMed ID: 33641310)
1. Group 2 innate lymphoid cells (ILC2s): The spotlight in asthma pathogenesis and lung tissue injury.
Sadik S; Lu Y; Zhu S; Cai J; Mi LL
Allergol Immunopathol (Madr); 2021; 49(2):208-216. PubMed ID: 33641310
[TBL] [Abstract][Full Text] [Related]
2. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.
LeSuer WE; Kienzl M; Ochkur SI; Schicho R; Doyle AD; Wright BL; Rank MA; Krupnick AS; Kita H; Jacobsen EA
J Allergy Clin Immunol; 2023 Aug; 152(2):469-485.e10. PubMed ID: 37028525
[TBL] [Abstract][Full Text] [Related]
3. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
van Rijt L; von Richthofen H; van Ree R
Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
[TBL] [Abstract][Full Text] [Related]
4. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
5. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
6. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients.
Sugita K; Steer CA; Martinez-Gonzalez I; Altunbulakli C; Morita H; Castro-Giner F; Kubo T; Wawrzyniak P; Rückert B; Sudo K; Nakae S; Matsumoto K; O'Mahony L; Akdis M; Takei F; Akdis CA
J Allergy Clin Immunol; 2018 Jan; 141(1):300-310.e11. PubMed ID: 28392332
[TBL] [Abstract][Full Text] [Related]
7. Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics.
Ishii T; Muroi M; Horiguchi K; Tanamoto KI; Nagase T; Yamashita N
Clin Exp Allergy; 2019 Dec; 49(12):1624-1632. PubMed ID: 31494992
[TBL] [Abstract][Full Text] [Related]
8. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
Matsuyama T; Matsuyama H; Dotake Y; Takagi K; Machida K; Inoue H
Front Immunol; 2022; 13():930862. PubMed ID: 35911708
[TBL] [Abstract][Full Text] [Related]
9. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
10. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16.
Li Y; Chen S; Chi Y; Yang Y; Chen X; Wang H; Lv Z; Wang J; Yuan L; Huang P; Huang K; Corrigan CJ; Wang W; Ying S
Cell Mol Immunol; 2019 Jan; 16(1):75-86. PubMed ID: 30467418
[TBL] [Abstract][Full Text] [Related]
13. IL-13
Jia Y; Fang X; Zhu X; Bai C; Zhu L; Jin M; Wang X; Hu M; Tang R; Chen Z
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):675-683. PubMed ID: 27314535
[TBL] [Abstract][Full Text] [Related]
14. Progesterone amplifies allergic inflammation and airway pathology in association with higher lung ILC2 responses.
Trivedi S; Deering-Rice CE; Aamodt SE; Huecksteadt TP; Myers EJ; Sanders KA; Paine R; Warren KJ
Am J Physiol Lung Cell Mol Physiol; 2024 Jul; 327(1):L65-L78. PubMed ID: 38651968
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.
Oczypok EA; Milutinovic PS; Alcorn JF; Khare A; Crum LT; Manni ML; Epperly MW; Pawluk AM; Ray A; Oury TD
J Allergy Clin Immunol; 2015 Sep; 136(3):747-756.e4. PubMed ID: 25930197
[TBL] [Abstract][Full Text] [Related]
16. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.
Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D
Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
18. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma.
Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW
Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286
[TBL] [Abstract][Full Text] [Related]
20. Type 2 innate lymphoid cells-new members of the "type 2 franchise" that mediate allergic airway inflammation.
Mjösberg J; Spits H
Eur J Immunol; 2012 May; 42(5):1093-6. PubMed ID: 22539283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
